Rural and Remote Community Cancer Screening Challenge
This challenge is open and accepting submissions for Phase 1 from May 8 to July 3, 2025 5:00pm ET. To learn more about how to apply, register for and attend our informational webinar on May 27 at 12–1 p.m. EDT.
In partnership with the Canadian Cancer Society
Challenge description
Rural and remote communities in Canada receive less funding for healthcare and have less health infrastructure. People living in these regions are also more likely to die from cancer.
Getting screened for cancer before symptoms appear has the potential to detect cancer early, and save lives. However, in rural and remote communities, there are inconsistent approaches to informing and educating people about the importance of getting screened for cancer, and there are challenges unique to these regions that aren’t being addressed.
MaRS and the Canadian Cancer Society are working to change this. To help save and improve lives, the Rural and Remote Community Cancer Screening Challenge is looking for solutions that increase participation in cancer screening in rural and remote communities.
Who should participate
- Rural and remote community organizations and advocates
- Indigenous community hubs and resource centres
- Practitioners in the healthcare and cancer sectors
- National, regional or community based non-profit organizations
- Health technology startups and founders
- Private/public sector institutions, including healthcare organizations
- Researchers
- People or groups with lived rural and/or remote experience
- Health system designers
- Anyone interested in creating more equitable solutions for healthcare
See which solutions are in scope and out of scope under “Challenge”
Prizing
A total of $175,000 will be awarded across two phases. See the Prizing tab for more details.
What’s happening now
This challenge is open and accepting submissions for Phase 1 from May 8 to July 3, 2025. To learn more about how to apply, register for and attend our informational webinar on May 27 at 12–1 p.m. EDT.
The problem
Cancer remains a leading cause of death in Canada. Two out of every five people in Canada are expected to develop cancer in their lifetime, and one in four will die as a result of the disease.
Residents of rural and remote communities have higher cancer-related mortality rates than their urban counterparts. These communities receive less funding for healthcare and have less health infrastructure.
Getting screened for cancer before symptoms appear has the potential to detect cancer early, and save lives. However, in rural and remote communities, informing and educating people to get screened for cancer is not consistent and there are challenges unique to these regions that aren’t being addressed.
We need solutions that recognize the insights and expertise that exist in these communities, and leverage those strengths for long-term impact.
Cancer screening in Canada
Cancer screening is the process of testing for signs of cancer before symptoms occur. While screening does not diagnose cancer, it can lead to earlier detection, faster recovery and improved survival rates.
Canada’s organized screening programs cover breast, colorectal, lung and cervical cancers, with eligibility and testing methods varying by cancer type and jurisdiction.
There are multiple steps to the cancer screening process.
- Recruitment: Eligible individuals are identified and informed through healthcare provider referrals, self-referrals or program invitations.
- Testing: Next, a screening test is conducted. This test may be self-administered, such as a fecal immunochemical test (FIT), human papillomavirus (HPV) test, or administered by a healthcare provider, such as a CT scan or Pap smear.
- Follow-up: The results of the screening test are communicated to the individual. If cancer is detected, more tests may be needed for timely treatment and better health outcomes. If there are no indications of cancer, no immediate follow-up is required, but the individual should still be re-engaged for future screening according to program guidelines.
Cancer screening in rural and remote communities
More than 6 million people in Canada (roughly 16 percent of the population) live in rural and remote communities in Canada, which face significant healthcare challenges that impact cancer outcomes. These regions tend to have older populations and lower incomes, and intersect with Indigenous communities. Rural reflects population size, while remote reflects geography. For the Canadian Cancer Society, a community is considered rural or remote when it has a population of 10,000 or less or because geography has limited people’s access to healthcare facilities and services.
Inconsistent methods of informing and engaging individuals and failure to address the unique barriers faced by rural and remote populations contribute to disparities in cancer outcomes. As a result, rural populations are less likely to survive cancer compared to their urban counterparts, highlighting the urgent need for improved screening accessibility and healthcare support in these regions.
Barriers to screening in rural and remote communities
Access to preventative care in rural and remote communities remains a major barrier, with fewer physicians per capita, limited availability of primary care, longer travel times, higher costs and increased reliance on emergency departments for non-urgent issues. Many residents lack a primary healthcare provider, making members of these communities less likely to access or participate in cancer screening.
The most significant barriers to screening in rural and remote communities fall into four categories:
Infrastructural barriers:
- Limited healthcare staff and facilities: Lack of screening centres, community healthcare facilities, and fewer physicians and healthcare practitioners reduce accessibility to cancer screening.
- Digital divide: Limited internet access, network issues and lack of digital literacy as well as fewer devices, hampers the effectiveness of digital health resources.
- Jurisdictional: Disputes among different levels of government over healthcare responsibility for Indigenous peoples create service gaps.
- Informational: Inconsistent eligibility data and patient outreach methods hinder screening access.
Cultural barriers:
- Knowledge translation: Promotional language can be unclear and unrelatable for rural and remote communities, which can make information inaccessible.
- Accessibility and cultural safety: The environment where screening occurs and the practitioners who conduct the test can affect an individual’s comfort level around screening. Cultural safety concerns, including mistrust in the healthcare system, can be a barrier for some communities, including Indigenous populations. A gap in culturally appropriate care continues to affect people’s willingness to access screening and health services.
Socio-economic barriers:
- Income/employment disruption: Rural and remote residents often have to take unpaid leave for cancer screening and follow-up care.
- Out of pocket expenses: Often called a “rural tax,” rural and remote communities face extra costs for care, including travel, vehicle wear, fuel and accommodations.
- Conflicting priorities: In rural and remote communities, cancer screening is not a top priority compared to other issues such as employment and access to safe water supply.
Geographical barriers:
- Distance to facilities: The location of healthcare facilities affects a person’s ability to participate in screening.
- Environmental conditions: Harsh weather conditions can disrupt travel and cause road closures, limiting access to care.
A note about Indigenous communities: While most Indigenous peoples live in urban areas, there is still a notable Indigenous presence in rural and remote regions of Canada. Some Indigenous people face barriers and inequities to healthcare access that may be exacerbated by prejudicial treatment and racism, as well as the ongoing effects of colonialism. Although Indigenous peoples are not the sole focus of this challenge, solutions that are designed and led by these communities are welcome and encouraged.
Challenge statement: Call to action
MaRS and the Canadian Cancer Society invite communities, individuals and teams to identify solutions to better inform, encourage and engage more people from rural and remote communities to get screened for cancer, ultimately increasing participation in screening.**
The challenge welcomes both non-technological and technological solutions and is open to a wide range of approaches such as community engagement/partnership models, education/communication methods and tools, process improvement and data collection and coordination.
Shortlisted solutions will need to meet the following requirements:
- Be designed by or co-designed with members of the rural and remote communities
- Be enhancements to existing models/programs/technology
- Be feasible and demonstrate potential for impact and scalability
- Be focused on at least one of Canada’s organized screening programs (breast, colorectal, lung or cervical cancers)
**Please note that the focus of this challenge is not on new screening tests, but rather, on the process to encourage people to take established tests.
What solutions are in scope?
The challenge is open to a variety of mature solutions both technological and non-technological, that increase participation in breast, colorectal, lung or cervical cancer screening in rural and remote communities. For tech solutions, “mature” refers to a validated product. Solutions will need to address at least one barrier identified in the Context tab (such as cultural and infrastructural). A wide range of interventions and enhancements will be considered, such as:
- Community engagement and partnership approaches
- Educational methods and materials
- Communication tools and methods
- Health system process improvement (digital or program)
- Data collection and/or coordination
Examples can include but are not limited to:
- Programs currently or recently implemented in rural and remote regions
- Proven solutions from other jurisdictions that have partnerships in place to scale or adapt to a rural or remote community
- A digital health tool with some level of demonstrated implementation that can adapt, scale or grow in rural and remote areas
- Research models that have strong data to support feasibility or implementation
What solutions are out of scope?
Solutions that are out of scope include:
- Solutions that are entirely new, with no prior testing or evidence of effectiveness
- Solutions that lack community involvement: Any intervention not designed with or informed by rural and remote communities
- Solutions that duplicate existing programs but without addressing an unmet need, new context, or added value to rural or remote communities
- New or enhancements to existing diagnostic tests*** for screening, such as:
- Home testing kits, such as Fecal Immunochemical Test (FIT), Immunochemical Fecal Occult Blood Test (iFOBT)
- Laboratory tests, such as blood or urine tests
- Imaging tests, such as computerized tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, ultrasound
- Biopsies
- Endoscopy tests as primary colorectal cancer screening tests, such as flexible sigmoidoscopy, colonoscopy
***Note that while screening tests are out of scope, the methods and approaches to get people to take the screening tests are in scope.
Eligibility
- For individuals: (a) you are a legal resident of Canada, and (b) you are at least the age of majority in your resident province.
- For groups: You are a group of individuals entering the Challenge as a team and:
(a) each of you, at the time of entry, is
(i) a legal resident of Canada, and
(ii) at least the age of majority in your resident province; and
(b) you designate one member of your team as your eligible authorized representative to enter the challenge and signify your agreement to be legally bound by these official rules on your behalf.
- For a company or organization:
(a) at the time of entry, is either
(i) incorporated under the laws of Canada; or
(ii) operating in Canada
(b) you designate one eligible authorized representative to enter the challenge and agree to be legally bound by these official rules on your behalf.
For more information, please review the challenge rules.
Dual phase process
This challenge will consist of two phases. Five finalists who are selected in Phase 1 will implement their solution in Phase 2. Between September 2025-January 2026, finalists have the ability to decide what elements of their solution they will implement and the duration. Finalists must submit their Phase 2 submission form by February 16, 2026 (or anytime before). Only those selected in the first phase, will be eligible to apply for the Grand Prize funding in the second phase. Finalists also have the ability to opt out of phase 2, if they no longer want to apply for the Grand Prize funding.
Please refer to the challenge rules for more details.
PHASE 1:
Phase 1 application: This open call for solutions will run from May 8 to July 3, 2025. Applicants can apply by submitting a Phase 1 submission form.
Phase 1 finalist notification: Five finalists of Phase 1 will be selected in August 2025 and will receive $15,000.
PHASE 2:
Solution implementation: The five finalists from Phase 1 will implement their proposed solution to increase participation within a rural and remote community for at least one of Canada’s organized screening programs (as outlined in their Phase 1 submission form) by January 2026.
Phase 2 submission: The five finalists from Phase 1 will submit a Phase 2 submission form using the entry methods outlined in the challenge rules. The submission deadline for Phase 2 is February 16, 2026.
Grand Prize winner: The Grand Prize winner of $100,000 will be selected at the end of Phase 2 and announced in April 2026.
PROGRESS REPORT:
Grand Prize winner progress report: The grand prize winner of Phase 2 of the challenge must complete progress reports with updates on their initiative at the six-month and 12-month marks.
How to apply for Phase 1
The submission deadline for Phase 1 is July 3 at 5 p.m. EDT. You can apply either through the website or via email. If you require another submission format or have any questions, contact us at challenges@marsdd.com. We also understand and recognize that Indigenous communities have unique values and systems. We are open to discuss alternate types of questions and/or supporting the application process. Please reach out to us via email.
In order to apply, follow the steps below.
Step 1: Create a profile on https://challenges.marsdd.com/
Step 2: Read and agree to the challenge rules by clicking the “Accept Challenge” button on the Rural and Remote Community Cancer Screening website.
Step 3: Complete the submission form:
- Be sure to adhere to the word-count parameters.
- Save in Word or PDF format with your team/applicant name and date listed in the file name (e.g. Team-MaRS_June2025_ Submission-Form).
Step 4:
- To submit through the Challenge website: Click “Submit application” on the Rural and Remote Community Cancer Screening webpage, and upload your saved submission form.
- Alternatively, to submit using email: Send an email to challenges@marsdd.com with the subject line of “Rural and Remote Cancer Screening Challenge Submission” that includes a pdf or word document of the submission form.
Prizing
A total amount of $175,000 will be awarded as follows:
Phase 1: Five finalists will receive $15,000 each
Phase 2: One Grand Prize winner will receive $100,000
Phase 1: Evaluation criteria
The assessment of solutions will be based on the following criteria:
Design (Pass/Fail)
Is the solution co-designed/designed by communities?
Feasibility and Need (55%)
This will evaluate the practicality and necessity of the solution
- Is the solution grounded in lived experience, knowledge or research?
- Does the solution have the team, structure, and/or resources to viably implement?
- Are the proposed activities realistic and cost-effective within the context of rural and remote communities?
Potential for impact (30%)
This will evaluate the existing and future plan for identifying and capturing success
- Has the applicant clearly outlined what success looks like (in the form of goals and measures)?
- Does the application capture impact from a community member’s point of view or user experience?
- Does the applicant have a clear, realistic plan for capturing and reporting impact?
Viability (15%)
This will evaluate the likelihood of long-term implementation/commitment
- Is the project/initiative connected to the organization’s long-term goals or part of its business model?
- Has the team considered the downstream impact of solution implementation?
Phase 2: Evaluation criteria
Solutions will be assessed based on their real-world applications and their impacts on cancer screening and communities, as well as potential future applications.
Impact (35%)
This will evaluate the results of the implementation
- Did the solution achieve what the applicant set out to do?
- Were outcomes and specific measurements of success clearly captured and outlined?
- Is there evidence that the initiative is meaningful from a community member’s point of view?
Scalability and Sustainability (35%)
This will evaluate the potential for growth and further impact
- Can the model or solution be replicated or modified in other jurisdictions?
- Has the applicant identified a pathway to grow this work? (How has cost-effectiveness been considered?)
Adaptive Problem Solving (30%)
This will evaluate the applicant’s ability to adapt to challenges, iterate and share learnings
- How did the applicant adapt to unknown challenges during implementation?
- Did the applicant introduce novel ideas or approaches during the implementation of its solution?
- Did the applicant have a process to capture and communicate lessons learned?
Timeline
Challenge launch (08/05/2025)
This post is also available in: Français
Informational webinar (27/05/2025)
This post is also available in: Français
12–1 p.m. EDT
Submission deadline (03/07/2025)
This post is also available in: Français
5 p.m. EDT
Finalists announced (05/08/2025)
This post is also available in: Français
Solution Implementation (01/09/2025)
This post is also available in: Français
September 2025 – January 2026
Phase 2 Submission deadline (16/02/2026)
This post is also available in: Français
5 p.m. EDT
Grand Prize Winner announced (27/04/2026)
This post is also available in: Français
Challenge Rules
Phase 1 Submission Form
PHASE 2 Submission Form (Currently not accepting submissions)
Useful Links
FAQ
For individuals:
- You are a legal resident of Canada, and
- You are at least the age of majority in your resident province or territory.
For groups:
Each member of the team, at the time of entry, is:
- a legal resident of Canada, and
- at least the age of majority in their resident province or territory.
For companies or organizations:
At the time of entry, the company or organization is either
- incorporated under the laws of Canada, or
- operating in Canada.
You are ineligible to participate in the challenge if:
- You are an employee of MaRS or the Canadian Cancer Society; or
- You are an immediate family member of a MaRS or Canadian Cancer Society employee.
No. All submissions are kept private and no details are shared with other participants.
Yes, your solution should address at least one of the four cancers that are part of the organized cancer screening program: lung, cervical, colorectal or breast.
Five finalists and one Grand Prize winner will be selected by a panel of expert judges based on the challenge evaluation criteria. Please see the challenge rules to find out about the evaluation criteria.
Two phases refers to both the process as well as prizing distribution.
All eligible applicants can apply for the first phase (deadline is July 3, 2025). Only those selected in the first phase, will be eligible to apply for the Grand Prize funding in the second phase.
Prizing will be distributed in two phases. (Please refer to the prizing tab for more details.)
As part of the research and design process, subject matter experts with lived experience and work experience in rural and/or remote communities were consulted. In addition, MaRS and the Canadian Cancer Society convened a pan-Canadian advisory council of experts to provide feedback and advice on the design of this challenge. We recognize that each person we spoke to represents only their own experience, not entire populations, regions or systems.
Technological solutions may include innovations, such as digital tools, medical devices, AI applications or telehealth platforms that improve access, efficiency or accuracy in cancer screening.
Non-technological solutions refer to improvements that don’t rely on new tech, such as process enhancements within organized screening programs, system-level strategies adapted from other sectors, new partnership models, innovative approaches to impact measurement, and reimagined health promotion and education strategies.
Please email challenges@marsdd.com and we will be happy to answer your question or arrange a time to connect virtually.
If you have a mature solution that is focused on another community/jurisdiction, it may still be eligible for this challenge if the proposed enhancement:
- focuses on a rural or remote community and,
- has been co-designed with people from a rural or remote community.
Rural reflects population size, while remote reflects geography. For the purpose of this challenge, a community is considered rural or remote when it has a population of 10,000 or less or because geography has limited people’s access to healthcare facilities and services.
This challenge focuses on solutions that increase participation in cancer screening and not on the screening tests themselves. If, as a part of developing your screening test, you have developed tools/programs that can increase participation (such as educational tools or awareness campaigns), those programs/tools may be eligible.
You can submit a maximum of one entry per individual, team or organization. If you have submitted a solution as part of a team, you cannot submit another solution as an individual.
Please contact the MaRS team at challenges@marsdd.com for help and to discuss in more detail.
This post is also available in: Français
Canadian Cancer Society
The Canadian Cancer Society works tirelessly to save and improve lives. We raise funds to fuel the brightest minds in cancer research. We provide a compassionate support system for all those affected by cancer, across Canada and for all types of cancer. Together with patients, supporters, donors and volunteers, we work to create a healthier future for everyone. Because to take on cancer, it takes all of us. It takes a society.